Calyxt, Inc. (CLXT)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Calyxt, Inc. (CLXT) trades at $31.50 with AI Score 43/100 (Weak). Calyxt, Inc. is a synthetic biology company focused on delivering plant-based solutions to the agriculture market. Market cap: 32M, Sector: Consumer defensive.
Last analyzed: Feb 8, 2026Calyxt, Inc. (CLXT) Consumer Business Overview
Calyxt, Inc. pioneers plant-based solutions for agriculture, leveraging synthetic biology to enhance crop digestibility and fiber content. With a focus on alfalfa, hemp, and wheat, Calyxt offers innovative solutions for a growing market, underscored by a commercialization agreement with S&W Seed Company.
Investment Thesis
Investing in Calyxt, Inc. presents a unique opportunity to capitalize on the growing demand for innovative agricultural solutions. The company's focus on synthetic biology and plant-based innovation positions it at the forefront of the evolving agriculture industry. Calyxt's commercialization agreement with S&W Seed Company for improved alfalfa provides a clear pathway to revenue generation. The company's focus on hemp and high-fiber wheat addresses emerging market needs. However, potential investors should be aware of the company's negative profit margin of -4824.5% and high beta of 2.04, indicating significant volatility. Key value drivers include successful commercialization of its alfalfa, hemp, and wheat products, along with strategic partnerships. Upcoming catalysts include further advancements in its hemp and wheat programs.
Based on FMP financials and quantitative analysis
Key Highlights
- Market Cap of $0.03B indicates a small-cap company with potential for growth but also higher risk.
- Gross Margin of 24.2% demonstrates the company's ability to generate revenue above the direct costs of production.
- P/E Ratio of -1.13 reflects the company's current lack of profitability.
- Beta of 2.04 suggests the stock is more volatile than the market average.
- Commercialization agreement with S&W Seed Company provides a revenue stream for improved alfalfa seed.
Competitors & Peers
Strengths
- Innovative synthetic biology platform.
- Focus on improving crop traits.
- Commercialization agreement with S&W Seed Company.
- Proprietary intellectual property.
Weaknesses
- Negative profit margin.
- High beta indicating volatility.
- Limited product portfolio.
- Small market capitalization.
Catalysts
- Upcoming: Expansion of commercialization of improved alfalfa seed with S&W Seed Company.
- Ongoing: Development and potential commercialization of hemp products.
- Ongoing: Progress in the development of high-fiber wheat varieties.
Risks
- Potential: Regulatory challenges related to genetically modified crops.
- Potential: Competition from larger, more established agricultural companies.
- Ongoing: Financial losses and need for additional funding.
- Ongoing: Dependence on the success of key partnerships.
Growth Opportunities
- Expansion of Alfalfa Commercialization: Calyxt's commercialization agreement with S&W Seed Company provides a strong foundation for growth in the alfalfa market. By expanding the geographic reach and market penetration of its improved alfalfa seed, Calyxt can significantly increase its revenue. The global alfalfa market is estimated to be worth billions of dollars, offering substantial growth potential for Calyxt over the next 3-5 years.
- Hemp Product Development: Calyxt is actively involved in developing hemp products with improved traits. As the market for hemp-based products continues to grow, Calyxt can capitalize on this trend by introducing innovative hemp varieties with enhanced characteristics. The global hemp market is projected to reach billions of dollars in the coming years, presenting a significant growth opportunity for Calyxt within the next 2-4 years.
- High-Fiber Wheat Innovation: Calyxt's development of wheat with higher fiber content addresses the growing demand for healthier food options. By successfully commercializing its high-fiber wheat, Calyxt can tap into the large and established wheat market. The market for high-fiber foods is expanding, driven by increasing consumer awareness of the health benefits of dietary fiber, offering a long-term growth opportunity.
- Strategic Partnerships: Calyxt can pursue strategic partnerships with other companies in the agriculture and food industries to expand its market reach and access new technologies. Collaborations with seed companies, food processors, and agricultural technology providers can accelerate Calyxt's growth and enhance its competitive position. These partnerships can be established within the next 1-3 years.
- Intellectual Property Protection: Calyxt's intellectual property portfolio, including patents and proprietary technologies, provides a competitive advantage. By actively protecting and expanding its intellectual property, Calyxt can maintain its leadership position in the synthetic biology and plant-based solutions market. Continued investment in research and development is crucial for securing future intellectual property assets.
Opportunities
- Expanding alfalfa commercialization.
- Developing new hemp-based products.
- Commercializing high-fiber wheat.
- Forming strategic partnerships.
Threats
- Competition from established agricultural companies.
- Regulatory hurdles for genetically modified crops.
- Fluctuations in commodity prices.
- Dependence on key partnerships.
Competitive Advantages
- Proprietary synthetic biology technology.
- Intellectual property protection.
- Commercialization agreement with S&W Seed Company.
About CLXT
Calyxt, Inc., established in 2010 and headquartered in Roseville, Minnesota, is a synthetic biology company dedicated to revolutionizing the agriculture industry through plant-based solutions. Originally named Cellectis Plant Sciences, Inc., the company rebranded as Calyxt, Inc. in May 2015 to better reflect its focus on innovative plant breeding techniques. As a subsidiary of Cellectis S.A., Calyxt leverages advanced technologies to develop crops with improved traits, primarily targeting the agriculture end market in the United States. Calyxt's core business revolves around the development of crops with enhanced characteristics. Key products include improved digestibility alfalfa, hemp, and wheat with higher fiber content. The company's improved digestibility alfalfa aims to enhance animal feed efficiency, while its high-fiber wheat targets the growing demand for healthier food options. Calyxt has a commercialization agreement with S&W Seed Company for the exclusive license of its improved quality alfalfa seed in the United States and internationally, demonstrating its commitment to expanding its market reach and impact. The company operates primarily in the United States, focusing on delivering solutions to domestic agricultural producers.
What They Do
- Develop plant-based solutions for the agriculture market.
- Utilize synthetic biology to improve crop traits.
- Focus on enhancing digestibility and fiber content in crops.
- Develop improved digestibility alfalfa.
- Develop hemp with improved traits.
- Develop wheat with higher fiber content.
Business Model
- Develop and license improved crop varieties.
- Commercialize seeds through partnerships.
- Generate revenue through seed sales and licensing agreements.
Industry Context
Calyxt operates within the packaged foods industry, which is experiencing a shift towards healthier and more sustainable food options. The market for improved crops, particularly those with enhanced digestibility and higher fiber content, is growing. Calyxt's focus on synthetic biology positions it to capitalize on these trends. Competitors include companies like AIU (AI-Inspired Solutions), CASK (Cask Global Canning Solutions), GEHI (Green Earth Technologies Holdings, Inc.), HAPP (Happiness Biotech Group Limited), and IMG (International Meal Company Alimentacao S.A.), each with varying approaches to food and agriculture. The overall packaged foods market is expected to continue growing, driven by changing consumer preferences and increasing demand for convenience foods.
Key Customers
- Agricultural producers.
- Seed companies.
- Food processors.
Financials
Chart & Info
Calyxt, Inc. (CLXT) stock price: $31.50 (+25.55, +428.97%)
Latest News
-
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga · Jan 18, 2023
-
Nasdaq Edges Higher; Neovasc Shares Jump
benzinga · Jan 17, 2023
-
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
benzinga · Jan 17, 2023
-
12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga · Jan 17, 2023
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CLXT.
Price Targets
Wall Street price target analysis for CLXT.
MoonshotScore
What does this score mean?
The MoonshotScore rates CLXT's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Nasdaq Edges Higher; Neovasc Shares Jump
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
What Investors Ask About Calyxt, Inc. (CLXT)
What does Calyxt, Inc. do?
Calyxt, Inc. is a synthetic biology company focused on developing and commercializing plant-based solutions for the agriculture industry. The company utilizes advanced technologies to improve crop traits, with a focus on enhancing digestibility and fiber content. Calyxt's primary products include improved digestibility alfalfa, hemp, and wheat with higher fiber content. The company generates revenue through seed sales and licensing agreements, primarily targeting agricultural producers in the United States and internationally through its partnership with S&W Seed Company.
Is CLXT stock worth researching?
Investing in CLXT stock involves both opportunities and risks. The company's innovative technology and focus on improving crop traits offer potential for growth. The commercialization agreement with S&W Seed Company provides a clear revenue stream. However, Calyxt's negative profit margin and high beta indicate significant financial challenges and volatility. Investors should carefully consider their risk tolerance and conduct thorough due diligence before investing in CLXT.
What are the main risks for CLXT?
Calyxt faces several key risks, including regulatory hurdles for genetically modified crops, competition from larger agricultural companies, and dependence on key partnerships. The company's financial losses and need for additional funding also pose a significant risk. Furthermore, fluctuations in commodity prices and changes in consumer preferences could impact the demand for Calyxt's products. Investors should be aware of these risks before investing in CLXT.
What are the key factors to evaluate for CLXT?
Calyxt, Inc. (CLXT) currently holds an AI score of 43/100, indicating low score. Key strength: Innovative synthetic biology platform.. Primary risk to monitor: Potential: Regulatory challenges related to genetically modified crops.. This is not financial advice.
How frequently does CLXT data refresh on this page?
CLXT prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven CLXT's recent stock price performance?
Recent price movement in Calyxt, Inc. (CLXT) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Innovative synthetic biology platform.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider CLXT overvalued or undervalued right now?
Determining whether Calyxt, Inc. (CLXT) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying CLXT?
Before investing in Calyxt, Inc. (CLXT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Stock data pending update. Financial data based on available information as of 2026-02-08.